ReviewRSC advances2022

Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs.

Ajay Sharma S et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.